世界の動物用医薬品調剤市場2020-2030:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Animal Drug Compounding Market (Product: Anti-infectives, Anti-inflammatory, CNS Agents, GI Drugs, and Others; Animal Type: Companion Animal and Livestock Animal; Dosage Form: Capsule, Suspension, Solution, Powders, and Others; and Route of Administration: Oral, Injectable, Topical, Rectal, and Ocular) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Animal Drug Compounding Market (Product: Anti-infectives, Anti-inflammatory, CNS Agents, GI Drugs, and Others; Animal Type: Companion Animal and Livestock Animal; Dosage Form: Capsule, Suspension, Solution, Powders, and Others; and Route of Administration: Oral, Injectable, Topical, Rectal, and Ocular) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030「世界の動物用医薬品調剤市場2020-2030:産業分析、規模、シェア、成長、動向、予測」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2104A010
• 出版社/出版日:Transparency Market Research / 2021年3月19日
• レポート形態:英文、PDF、256ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥620,065 (USD5,795)▷ お問い合わせ
  Site Licence¥941,065 (USD8,795)▷ お問い合わせ
  Enterprise Licence¥1,262,065 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査資料では、世界の動物用医薬品調剤市場を広く調査・分析し、序論、仮定・調査手法、製品別(抗感染薬、抗炎症薬、中枢神経系用薬、胃腸薬、その他)分析、動物タイプ別分析、剤形別分析、投与経路別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの構成でまとめております。
・序論
・仮定・調査手法
・世界の動物用医薬品調剤市場規模:製品別(抗感染薬、抗炎症薬、中枢神経系用薬、胃腸薬、その他)
・世界の動物用医薬品調剤市場規模:動物タイプ別
・世界の動物用医薬品調剤市場規模:剤形別
・世界の動物用医薬品調剤市場規模:投与経路別
・世界の動物用医薬品調剤市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Animal Drug Compounding Market – Scope of the Report

TMR’s report on the global animal drug compounding market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global animal drug compounding market for the period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global animal drug compounding market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global animal drug compounding market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global animal drug compounding market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global animal drug compounding market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global animal drug compounding market. The next section of the global animal drug compounding market report highlights the USPs, which include technological advancements, regulatory scenario across globe, overview of animal drug compounding (benefits, risks, challenges, etc.), and COVID-19 pandemic impact on global animal drug compounding market.

The report delves into the competition landscape of the global animal drug compounding market. Key players operating in the global animal drug compounding market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global animal drug compounding market report.

Key Questions Answered in Animal Drug Compounding Market Report

What are the sales/revenue generated by animal drug compounding across all regions during the forecast period?
What are the key trends in the global animal drug compounding market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2030 and which segment will grow at the highest CAGR during the forecast period?
What was the market share of different companies operating in the global market in 2019?
What were the strengths and weaknesses of major players in 2019?
What was the competitive analysis of major players in 2019?
What was the market share analysis of different companies operating in the global market in 2019?
Animal Drug Compounding Market – Research Objectives and Research Approach

The comprehensive report on the global animal drug compounding market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global animal drug compounding market. It is followed by market introduction, market dynamics, and an overview of the global animal drug compounding market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global animal drug compounding market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global animal drug compounding market in terms of value. The forecast presented here assesses the total revenue generated in the global animal drug compounding market. In order to provide an accurate forecast, we initiated by sizing up the current animal drug compounding market with the help of the parent market.

The report analyzes the global animal drug compounding market in terms of product, animal type, dosage form, route of administration, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global animal drug compounding market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Global Animal Drug Compounding Market Analysis and Forecast, by Product
3.1. Introduction & Definition
3.2. Key Findings / Developments
3.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
3.3.1. Anti-infectives
3.3.1.1. Metronidazole
3.3.1.2. Ketoconazole
3.3.1.3. Other Antibiotics
3.3.2. Anti-inflammatory
3.3.2.1. Prednisolone
3.3.2.2. Tramadol
3.3.2.3. Other Anti inflammatory
3.3.3. CNS Agents
3.3.3.1. Potassium bromide
3.3.3.2. Gabapentin
3.3.3.3. Other CNS agents
3.3.4. GI Drugs
3.3.4.1. Apomorphine
3.3.4.2. Ursodiol
3.3.4.3. Cisapride
3.3.4.4. Other GI Drugs
3.3.5. Others
3.3.5.1. Methimazole
3.3.5.2. Other drugs
3.4. Market Attractiveness Analysis, by Product
4. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type
4.1. Introduction & Definition
4.2. Key Findings / Developments
4.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
4.3.1. Companion Animal
4.3.1.1. Dogs
4.3.1.2. Cats
4.3.1.3. Others
4.3.2. Livestock
4.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Animal Type
5. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
5.3.1. Capsule
5.3.2. Solution
5.3.3. Powders
5.3.4. Suspension
5.3.5. Others
5.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form
6. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
6.3.1. Oral
6.3.2. Injectable
6.3.3. Topical
6.3.4. Rectal
6.3.5. Ocular
6.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration
7. Global Animal Drug Compounding Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Global Animal Drug Compounding Market Attractiveness Analysis, by Region
8. North America Animal Drug Compounding Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
8.2.1. Anti-infectives
8.2.1.1. Metronidazole
8.2.1.2. Ketoconazole
8.2.1.3. Other Antibiotics
8.2.2. Anti-inflammatory
8.2.2.1. Prednisolone
8.2.2.2. Tramadol
8.2.2.3. Other Anti inflammatory
8.2.3. CNS Agents
8.2.3.1. Potassium Bromide
8.2.3.2. Gabapentin
8.2.3.3. Other CNS agents
8.2.4. GI Drugs
8.2.4.1. Apomorphine
8.2.4.2. Ursodiol
8.2.4.3. Cisapride
8.2.4.4. Other GI Drugs
8.2.5. Others
8.2.5.1. Methimazole
8.2.5.2. Other drugs
8.3. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
8.3.1. Companion Animal
8.3.1.1. Dogs
8.3.1.2. Cats
8.3.1.3. Others
8.3.2. Livestock Animal
8.4. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
8.4.1. Capsule
8.4.2. Solution
8.4.3. Powders
8.4.4. Suspension
8.4.5. Others
8.5. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
8.5.1. Oral
8.5.2. Injectable
8.5.3. Topical
8.5.4. Rectal
8.5.5. Ocular
8.6. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
8.6.1. U.S.
8.6.2. Canada
9. Europe Animal Drug Compounding Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
9.2.1. Anti-infectives
9.2.1.1. Metronidazole
9.2.1.2. Ketoconazole
9.2.1.3. Other Antibiotics
9.2.2. Anti-inflammatory
9.2.2.1. Prednisolone
9.2.2.2. Tramadol
9.2.2.3. Other Anti inflammatory
9.2.3. CNS Agents
9.2.3.1. Potassium Bromide
9.2.3.2. Gabapentin
9.2.3.3. Other CNS agents
9.2.4. GI Drugs
9.2.4.1. Apomorphine
9.2.4.2. Ursodiol
9.2.4.3. Cisapride
9.2.4.4. Other GI Drugs
9.2.5. Others
9.2.5.1. Methimazole
9.2.5.2. Other drugs
9.3. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
9.3.1. Companion Animal
9.3.1.1. Dogs
9.3.1.2. Cats
9.3.1.3. Others
9.3.2. Livestock Animal
9.4. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
9.4.1. Capsule
9.4.2. Solution
9.4.3. Powders
9.4.4. Suspension
9.4.5. Others
9.5. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
9.5.1. Oral
9.5.2. Injectable
9.5.3. Topical
9.5.4. Rectal
9.5.5. Ocular
9.6. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
9.6.1. Germany
9.6.2. U.K.
9.6.3. France
9.6.4. Italy
9.6.5. Spain
9.6.6. Rest of Europe
10. Asia Pacific Animal Drug Compounding Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
10.2.1. Anti-infectives
10.2.1.1. Metronidazole
10.2.1.2. Ketoconazole
10.2.1.3. Other Antibiotics
10.2.2. Anti-inflammatory
10.2.2.1. Prednisolone
10.2.2.2. Tramadol
10.2.2.3. Other Anti inflammatory
10.2.3. CNS Agents
10.2.3.1. Potassium Bromide
10.2.3.2. Gabapentin
10.2.3.3. Other CNS agents
10.2.4. GI Drugs
10.2.4.1. Apomorphine
10.2.4.2. Ursodiol
10.2.4.3. Cisapride
10.2.4.4. Other GI Drugs
10.2.5. Others
10.2.5.1. Methimazole
10.2.5.2. Other drugs
10.3. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
10.3.1. Companion Animal
10.3.1.1. Dogs
10.3.1.2. Cats
10.3.1.3. Others
10.3.2. Livestock Animal
10.4. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
10.4.1. Capsule
10.4.2. Solution
10.4.3. Powders
10.4.4. Suspension
10.4.5. Others
10.5. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
10.5.1. Oral
10.5.2. Injectable
10.5.3. Topical
10.5.4. Rectal
10.5.5. Ocular
10.6. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
10.6.1. China
10.6.2. Japan
10.6.3. India
10.6.4. Australia & New Zealand
10.6.5. Rest of Asia Pacific
11. Latin America Animal Drug Compounding Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Introduction
11.2.1. Key Findings
11.3. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
11.3.1. Anti-infectives
11.3.1.1. Metronidazole
11.3.1.2. Ketoconazole
11.3.1.3. Other Antibiotics
11.3.2. Anti-inflammatory
11.3.2.1. Prednisolone
11.3.2.2. Tramadol
11.3.2.3. Other Anti inflammatory
11.3.3. CNS Agents
11.3.3.1. Potassium Bromide
11.3.3.2. Gabapentin
11.3.3.3. Other CNS agents
11.3.4. GI Drugs
11.3.4.1. Apomorphine
11.3.4.2. Ursodiol
11.3.4.3. Cisapride
11.3.4.4. Other GI Drugs
11.3.5. Others
11.3.5.1. Methimazole
11.3.5.2. Other drugs
11.4. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
11.4.1. Companion Animal
11.4.1.1. Dogs
11.4.1.2. Cats
11.4.1.3. Others
11.4.2. Livestock Animal
11.5. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
11.5.1. Capsule
11.5.2. Solution
11.5.3. Powders
11.5.4. Suspension
11.5.5. Others
11.6. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
11.6.1. Oral
11.6.2. Injectable
11.6.3. Topical
11.6.4. Rectal
11.6.5. Ocular
11.7. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.7.1. Brazil
11.7.2. Mexico
11.7.3. Rest of Latin America
12. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Introduction
12.2.1. Key Findings
12.3. Introduction
12.3.1. Key Findings
12.4. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
12.4.1. Anti-infectives
12.4.1.1. Metronidazole
12.4.1.2. Ketoconazole
12.4.1.3. Other Antibiotics
12.4.2. Anti-inflammatory
12.4.2.1. Prednisolone
12.4.2.2. Tramadol
12.4.2.3. Other Anti inflammatory
12.4.3. CNS Agents
12.4.3.1. Potassium Bromide
12.4.3.2. Gabapentin
12.4.3.3. Other CNS agents
12.4.4. GI Drugs
12.4.4.1. Apomorphine
12.4.4.2. Ursodiol
12.4.4.3. Cisapride
12.4.4.4. Other GI Drugs
12.4.5. Others
12.4.5.1. Methimazole
12.4.5.2. Other drugs
12.5. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
12.5.1. Companion Animal
12.5.1.1. Dogs
12.5.1.2. Cats
12.5.1.3. Others
12.5.2. Livestock Animal
12.6. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
12.6.1. Capsule
12.6.2. Solution
12.6.3. Powders
12.6.4. Suspension
12.6.5. Others
12.7. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
12.7.1. Oral
12.7.2. Injectable
12.7.3. Topical
12.7.4. Rectal
12.7.5. Ocular
12.8. Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.8.1. GCC Countries
12.8.2. South Africa
12.8.3. Rest of Middle East & Africa
13. Competitive Landscape
13.1. Market Player – Competition Matrix (by tier and size of companies)
13.2. Company Profiles
13.2.1. Wedgewood Pharmacy
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Product Portfolio
13.2.1.3. Strategic Overview
13.2.1.4. SWOT Analysis
13.2.2. Triangle Compounding Pharmacy
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Product Portfolio
13.2.2.3. Strategic Overview
13.2.2.4. SWOT Analysis
13.2.3. Davis Islands Pharmacy
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Product Portfolio
13.2.3.3. Strategic Overview
13.2.3.4. SWOT Analysis
13.2.4. Custom Med Compounding Pharmacy
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Product Portfolio
13.2.4.3. Strategic Overview
13.2.4.4. SWOT Analysis
13.2.5. Central Compounding Center South
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Product Portfolio
13.2.5.3. Strategic Overview
13.2.5.4. SWOT Analysis
13.2.6. Wellness Pharmacy of Cary
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Product Portfolio
13.2.6.3. Strategic Overview
13.2.6.4. SWOT Analysis
13.2.7. Caringbah Compounding Pharmacy
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Product Portfolio
13.2.7.3. Strategic Overview
13.2.7.4. SWOT Analysis
13.2.8. Millers Pharmacy
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Product Portfolio
13.2.8.3. Strategic Overview
13.2.8.4. SWOT Analysis
13.2.9. Smith’s Pharmacy
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Product Portfolio
13.2.9.3. Strategic Overview
13.2.9.4. SWOT Analysis
13.2.10. Specialist Compounding Pharmacy Pte Ltd.
13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.10.2. Product Portfolio
13.2.10.3. Strategic Overview
13.2.10.4. SWOT Analysis
13.2.11. Tache Pharmacy
13.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.11.2. Product Portfolio
13.2.11.3. Strategic Overview
13.2.11.4. SWOT Analysis

List of Tables

Table 01: Global & Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 02: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 06: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 07: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 08: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 09: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 10: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 11: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 12: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 13: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 14: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 16: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 17: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 18: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 19: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 20: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 21: North America Animal Drug Compounding Market Size (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 22: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage form, 2018–2030

Table 23: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 24: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 26: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 27: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 28: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 29: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 30: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 31: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 32: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Types, 2018–2030

Table 33: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 34: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 35: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 36: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 37: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 38: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 39: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 40: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 41: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 42: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 43: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 44: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 45: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 46: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 47: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 48: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 49: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 50: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 51: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 52: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 53: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 54: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 55: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage form, 2018–2030

Table 56: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 57: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 58: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 59: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 60: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 61: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 62: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 63: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 64: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 65: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 66: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 67: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030


• 英文レポート名:Animal Drug Compounding Market (Product: Anti-infectives, Anti-inflammatory, CNS Agents, GI Drugs, and Others; Animal Type: Companion Animal and Livestock Animal; Dosage Form: Capsule, Suspension, Solution, Powders, and Others; and Route of Administration: Oral, Injectable, Topical, Rectal, and Ocular) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
• 日本語訳:世界の動物用医薬品調剤市場2020-2030:産業分析、規模、シェア、成長、動向、予測
• レポートコード:MRC2104A010お問い合わせ(見積依頼・ご注文・質問)